Antibody Response Six Months after SARS-CoV-2 mRNA Vaccination in Patients with Inflammatory Bowel Disease

Patients with inflammatory bowel disease (IBD) are recommended to receive vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), regardless of their immunosuppression status. Immunosuppressive medications represent a mainstay of therapy in moderate to severe IBD; however,...

Descripción completa

Detalles Bibliográficos
Autores principales: Frey, Sarah, Chowdhury, Reezwana, Connolly, Caoilfhionn M., Werbel, William A., Segev, Dorry L., Parian, Alyssa M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the AGA Institute 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8732901/
https://www.ncbi.nlm.nih.gov/pubmed/34998996
http://dx.doi.org/10.1016/j.cgh.2021.12.045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8732901/
https://www.ncbi.nlm.nih.gov/pubmed/34998996
http://dx.doi.org/10.1016/j.cgh.2021.12.045

Ejemplares similares